pentobarbital will lower the level or outcome of lumefantrine by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Coadministration with potent CYP3A4 inducers can lead to diminished serum concentrations and lack of antimalarial efficacypentobarbital will lessen the extent or impact of clozapine by impacting hepatic/intestin